4.8 Article

Associations between metabolites and pancreatic cancer risk in a large prospective epidemiological study

Journal

GUT
Volume 69, Issue 11, Pages 2008-2015

Publisher

BMJ PUBLISHING GROUP
DOI: 10.1136/gutjnl-2019-319811

Keywords

-

Funding

  1. Intramural Research Program of the National Cancer Institute, National Institutes of Health, Department of Health and Human Services
  2. US Army Medical Research Acquisition Activity through the Peer Review Cancer Research Program Discovery Award [W81XWH-12-1-0369]
  3. NATIONAL CANCER INSTITUTE [ZIACP010195] Funding Source: NIH RePORTER

Ask authors/readers for more resources

Objective To assess whether prediagnostic metabolites were associated with incident pancreatic ductal adenocarcinoma (PDAC) in a prospective cohort study. Design We conducted an untargeted analysis of 554 known metabolites measured in prediagnostic serum (up to 24 years) to determine their association with incident PDAC in a nested case-control study of male smokers (372 matched case-control sets) and an independent nested case-control study that included women and non-smokers (107 matched sets). Metabolites were measured using Orbitrap Elite or Q-E xactive high-resolution/accurate mass spectrometers. Controls were matched to cases by age, sex, race, date of blood draw, and follow-up time. We used conditional logistic regression adjusted for age to calculate ORs and 95% CIs for a 1 SD increase in log-metabolite level separately in each cohort and combined the two ORs using a fixed-effects meta-analysis. Results Thirty-one metabolites were significantly associated with PDAC at a false discovery rate <0.05 with 12 metabolites below the Bonferroni-corrected threshold (p<9.04x10(-5)). Similar associations were observed in both cohorts. The dipeptides glycylvaline, aspartylphenylalanine, pyroglutamylglycine, phenylalanylphenylalanine, phenylalanylleucine and tryptophylglutamate and amino acids aspartate and glutamate were positively while the dipeptides tyrosylglutamine and alpha-glutamyltyrosine, fibrinogen cleavage peptide DSGEGDFXAEGGGVR and glutathione-related amino acid cysteine-glutathione disulfide were inversely associated with PDAC after Bonferroni correction. Five top metabolites demonstrated significant time-varying associations (p<0.023) with the strongest associations observed 10-15 years after participants' blood collection and attenuated thereafter. Conclusion Our results suggest that prediagnostic metabolites related to subclinical disease, gamma-glutamyl cycle metabolism and adiposity/insulin resistance are associated with PDAC.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available